sign free newsletters sign free newsletters survival better expected genetically modified pathogen inactivated form poliovirus treat recurrent brain tumors showing researchers called encouraging long term survival phase 1 clinical trial published tuesday authors reported 21 percent patients alive years recurrence aggressive quickly lethal form brain cancer stubbornly resistant treatment new crop immunotherapies proven ineffective bleak backdrop early results suggest experimental poliovirus therapy invented duke cancer institute promise caveats study design weaknesses new data raise doubts therapy featured twice cbs news 60 minutes"--will live hype definitive answer come larger clinical trials devastating disease prognosis outcome patients poor long term survivors new